Preclinical proof of concept of SOL-257, a gene therapy targeting misfolded TDP-43 in ALS

被引：0
|
作者：
Hishiya, Akinori [1 ]
Cox, Gerald [1 ]
机构：
[1] SOLA Biosci, Natick, MA USA
来源：
MUSCLE & NERVE | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
145
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 34 条
  • [31] Targeting a6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models
    Lee, Ming Tatt
    Mouri, Akihiro
    Kubota, Hisayoshi
    Lee, Hsin-Jung
    Chang, Man-Hsin
    Wu, Chen-Yi
    Knutson, Daniel E.
    Mihovilovic, Marko
    Cook, James
    Sieghart, Werner
    Nabeshima, Toshitaka
    Chiou, Lih-Chu
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [32] Preclinical Proof-of-Concept: A Novel Hybrid Gene Therapy Approach to Treat Severe Early-Onset Ornithine Transcarbamylase Deficiency
    Kok, Bernard
    Ebeid, David
    Mishgin, Nairika
    Loveless, Ryan
    Hajj, Khal
    Nguyen, Tuyen
    Deng, Christopher
    Griffin, Peter
    Li, Mu
    Bennett, Michael
    Battiprolu, Pavan
    Warner, Brent
    Madison, Blair
    Rychak, Joshua
    MOLECULAR THERAPY, 2023, 31 (04) : 68 - 69
  • [33] G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons
    Jeffrey D. Rothstein
    Victoria Baskerville
    Sampath Rapuri
    Emma Mehlhop
    Paymaan Jafar-Nejad
    Frank Rigo
    Frank Bennett
    Sarah Mizielinska
    Adrian Isaacs
    Alyssa N. Coyne
    Acta Neuropathologica, 2024, 147
  • [34] G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons
    Rothstein, Jeffrey D.
    Baskerville, Victoria
    Rapuri, Sampath
    Mehlhop, Emma
    Jafar-Nejad, Paymaan
    Rigo, Frank
    Bennett, Frank
    Mizielinska, Sarah
    Isaacs, Adrian
    Coyne, Alyssa N.
    ACTA NEUROPATHOLOGICA, 2024, 147 (01)
1234